Assistant Professor, Medicine, Case Western Reserve University School of Medicine
Infectious Disease
Dr. Benigno Rodriguez, MD
|
|
Give Review
Benigno Rodriguez practices Infectious Disease. Dr. Benigno Rodriguez has written publications. He has 82 publications published with PubMed. The lastest publication is: 'Reply to Barrett, et al.'
Publications
- Prevention of SHIV transmission by topical IFN-β treatment.
- Oxidized LDL levels are increased in HIV infection and may drive monocyte activation.
- Current Practices of Screening for Incident Hepatitis C Virus (HCV) Infection Among HIV-Infected, HCV-Uninfected Individuals in Primary Care.
- Timing of complementary food introduction and age at diagnosis of type 1 diabetes: the SEARCH nutrition ancillary study (SNAS).
- Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non-AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment.
- Identification of Occult Fusobacterium nucleatum Central Nervous System Infection Using PCR Electrospray Ionization Mass Spectrometry (PCR/ESI-MS).
- Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection.
- Lymphoma Immune Reconstitution Inflammatory Syndrome in the Center for AIDS Research Network of Integrated Clinical Systems Cohort.
- HIV Viremia and Incidence of Non-Hodgkin Lymphoma in Patients Successfully Treated With Antiretroviral Therapy.
- Factors Associated with Delayed Hepatitis B Viral Suppression on Tenofovir Among HBV-HIV Coinfected Patients in the CNICS Cohort.
- Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretrovi...
- Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.
- Temporal Trends in Presentation and Survival for HIV-Associated Lymphoma in the Antiretroviral Therapy Era.
- Association of early HIV viremia with mortality after HIV-associated lymphoma.
- The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized trial.
- High Levels of Antiretroviral Use and Viral Suppression among Persons in HIV Care in the United States, 2010.
- Plasma proteome analysis reveals overlapping, yet distinct mechanisms of immune activation in chronic HCV and HIV infections.
- Interferon-? Is the Primary Plasma Type-I IFN in HIV-1 Infection and Correlates with Immune Activation and Disease Markers.
- Impaired T cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes.
- Trends and Disparities in Antiretroviral Therapy Initiation and Virologic Suppression Among Newly Treatment-Eligible HIV-Infected Individuals in North America, 2001-2009.
- Predictive Accuracy of the Veterans Aging Cohort Study Index for Mortality With HIV Infection: A North American Cross Cohort Analysis.
- Characterizing HIV transmission networks across the United States.
- Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
- Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.
- Dynamics of Immune Reconstitution and Activation Markers in HIV+ Treatment-Naïve Patients Treated with Raltegravir, Tenofovir Disoproxil Fumarate and Emtricitabine.
- Effect of Nadir CD4+ T Cell Count on Clinical Measures of Periodontal Disease in HIV+ Adults before and during Immune Reconstitution on HAART.
- Association between U.S. State AIDS Drug Assistance Program (ADAP) Features and HIV Antiretroviral Therapy Initiation, 2001-2009.
- CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?
- Effect of early versus deferred antiretroviral therapy for HIV on survival.
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.
- Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations.
- Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals.
- Hepatitis C virus-specific T-cell gamma interferon and proliferative responses are more common in perihepatic lymph nodes than in peripheral blood or liver.
- Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.
- A family cluster of five cases of group A streptococcal pneumonia.
- Can HIV-1 superinfection compromise antiretroviral therapy?
- Peripheral blood B cell subset skewing is associated with altered cell cycling and intrinsic resistance to apoptosis and reflects a state of immune activation in chron...
- Late presentation for human immunodeficiency virus care in the United States and Canada.
- Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.
- Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells.
- Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.
- Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.
- Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north ame...
- Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.
- Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems.
- Can immune-related genotypes illuminate the immunopathogenesis of cytomegalovirus disease in human immunodeficiency virus-infected patients?
- Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
- TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection.
- Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis.
- TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.
- Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation.
- A prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults.
- Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening.
- Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.
- Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption.
- Interferon-Alpha Administration Enhances CD8+ T Cell Activation in HIV Infection.
- Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C ...
- Impaired naive and memory B-cell responsiveness to TLR9 stimulation in human immunodeficiency virus infection.
- Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care.
- Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects.
- Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
- Frequencies of FoxP3+ naive T cells are related to both viral load and naive T cell proliferation responses in HIV disease.
- Plasma levels of B-lymphocyte stimulator increase with HIV disease progression.
- Systemic immune activation in HIV infection is associated with decreased MDC responsiveness to TLR ligand and inability to activate naive CD4 T-cells.
- Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells.
- Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression.
- Determinants of protection among HIVâexposed seronegative persons: an overview.
- Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection.
- Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.
- Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.
- In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.
- Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T cell receptor engagement.
- Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, c...
- Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell funct...
- HIV coinfection impairs CD28-mediated costimulation of hepatitis C virus-specific CD8 cells.
- Impaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially m...
- Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic success.
- Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART.
- Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients.
- Reply to Barrett, et al.
- Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.
Schools
Pontificia Universidad Javeriana Facultad De Medicina
Lakeside Hospital
University Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Case Western Reserve University - University Hospitals -
Pontifical Xavierian University
Hospital
-
University Hospitals Case Medical Center
Drug Facts
| NPI NUMBER | 1043230691 | |
| NPPES Provider LastName | RODRIGUEZ | |
| NPPES Provider FirstName | BENIGNO | |
| NPPES Provider ZIPCode | 441061716 | |
| NPPES Provider State | OH | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 1479.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 79.0 | |
| Percent Opioid Claims | 5.34 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043230691 |
| Last Name Of The Provider | RODRIGUEZ |
| First Name Of The Provider | BENIGNO |
| View All |
Similar Doctors
|
Dr. Praveen K. Gundelly, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. J Walton Tomford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Kalayjian, MD |
|
Dr. David A. Bobak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maja Babic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sorabh Dhar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rabin K. Shrestha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter D. Coakley, MD |
|
|
Dr. Ume L. Abbas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michelle V. Lisgaris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter M. Wiest, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven D. Mawhorter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Marta N. Jakubowycz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amy J. Ray, MD |
|
Dr. Christina S. Hirsch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lulette Tricia C. Bravo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohammad-Safa E. Sobhanie, MD
This Doctor is OpenDoctor Recommended.
|